ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Deebo
|
261 |
63K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
63K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
9 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
19 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Deebo
|
37 |
8.8K |
24 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
8 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Deebo
|
77 |
18K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
14 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
11 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Deebo
|
66 |
18K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Deebo
|
66 |
18K |
11 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
66
|
18K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
12 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Deebo
|
62 |
16K |
13 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Deebo
|
62 |
16K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Deebo
|
62 |
16K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
Deebo
|
62 |
16K |
17 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Deebo
|
31 |
11K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
31
|
11K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Deebo
|
58 |
17K |
7 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
17K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Deebo
|
58 |
17K |
8 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
17K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
24 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.3K
|
325K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Deebo
|
31 |
11K |
18 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
11K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Deebo
|
31 |
11K |
18 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
11K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Deebo
|
282 |
74K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
282
|
74K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Deebo
|
33 |
8.5K |
16 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.5K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Deebo
|
196 |
36K |
8 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
196
|
36K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
126
|
31K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
6 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
126
|
31K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
9 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
12 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
4 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
31K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Deebo
|
317 |
79K |
16 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
317
|
79K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
16 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
31K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
12 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
31K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
6 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
1.3K
|
325K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Deebo
|
196 |
36K |
6 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Deebo
|
126 |
31K |
8 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
126
|
31K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Deebo
|
1.3K |
325K |
7 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
1.3K
|
325K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Deebo
|
196 |
36K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
196
|
36K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Deebo
|
63 |
16K |
7 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
63
|
16K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Deebo
|
63 |
16K |
9 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
63
|
16K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Deebo
|
63 |
16K |
12 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
16K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Deebo
|
63 |
16K |
16 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
16K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Deebo
|
100 |
26K |
16 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
26K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Deebo
|
100 |
26K |
4 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
26K
|
4
|
|